Biochemical and immunologic predictors of efficacy of treatment or reinfection risk for Schistosoma mansoni

Am J Trop Med Hyg. 2006 Nov;75(5):904-9.

Abstract

Most Schistosoma mansoni infections are egg-negative after a single dose of oxamniquine. A cohort of 661 infected children was treated at 6-month intervals and assessed for nutritional and parasitological status. Initial biochemical and immunologic markers were measured in a subset of 84 children. All were treated at the start of therapy and at 6 months. Immunoglobulins only served as markers for active infection. No markers were predictive of cure or reinfection, except initial infection intensity and serum low-density lipoprotein. Ten percent were persistently infected and had no change in infection intensity at any time-point. Several factors suggest that this group was biologically different. In addition to failing to reduce their worm burden, they had significantly higher initial intensity of infection (100 versus 65 eggs/g, P = 0.001) and significantly lower initial serum low-density lipoprotein (72 versus 104 mg/dL, P = 0.045). The biologic plausibility of this observation is discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Animals
  • Child
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Predictive Value of Tests*
  • Recurrence*
  • Risk Factors
  • Schistosoma mansoni / immunology*
  • Schistosomiasis mansoni / drug therapy
  • Schistosomiasis mansoni / epidemiology
  • Schistosomiasis mansoni / physiopathology*
  • Treatment Outcome